The Scorecard: 1 Month Update: LAR Sell — Correct so far

Revisiting our Sell call on LAR: entry $6.70, latest $5.60, -16.4%.

This is a Scorecard review, revisiting a past LF0 research call against what actually happened.

Ticker: LAR Rating: Sell Published: 2026-09-06 Checkpoint: 2026-10-06 Entry price: $6.70 Latest price: $5.60 as of 2026-10-05 Stock return since entry: -16.4% Signal return: +16.4% Verdict: Correct so far

This is the 1-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.

Read the original LF0 analysis

What I Said

  • Rated Sell — the stock already discounts a recovery that is not yet visible in cash flow.
  • Strongest point: net debt/EBITDA is -4.1x TTM, so cash still exceeds debt.
  • Biggest risk: levered free cash flow is -$16.4M TTM, so the business is not self-funding.
  • Valuation is mixed: 19.8x forward P/E and 1.41x price/book are not cheap against 0.0% margins.
  • I would turn more constructive if Caucha

Peer Comparison

CompanyReturn Since Entry
LAR (this call)-16.4%
ALB-17.8%
LAC-14.9%
SGML-7.6%
SQM-12.5%

Why It’s Working (Or Not)

Entry $6.70, latest $5.60, stock return -16.4%. Verdict: Correct so far.

The September 2026 Cohort

Other directional calls published the same month:

TickerRatingEntryLatestStock ReturnSignal ReturnVerdict
ASXSell$41.63$47.53+14.2%-14.2%Incorrect so far
TLNSell$294.54$331.87+12.7%-12.7%Incorrect so far
RXTSell$3.49$3.90+11.7%-11.7%Incorrect so far
ICHRSell$59.42$63.33+6.6%-6.6%Incorrect so far
PLSell$16.42$17.36+5.7%-5.7%Incorrect so far
SIMOSell$269.00$282.45+5.0%-5.0%Incorrect so far
ALABSell$351.31$362.34+3.1%-3.1%Incorrect so far
ATISell$189.65$193.09+1.8%-1.8%Incorrect so far
DOCNSell$136.29$137.23+0.7%-0.7%Incorrect so far
CCJSell$88.07$87.47-0.7%+0.7%Correct so far
BORRSell$4.44$4.15-6.5%+6.5%Correct so far
CHTRSell$117.55$107.77-8.3%+8.3%Correct so far
CUESell$26.96$24.36-9.6%+9.6%Correct so far
ACHRSell$5.26$4.72-10.3%+10.3%Correct so far

Live LF0 scorecard: The Scorecard | Research Performance dashboard

Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.

Research disclaimer

This material is provided for research and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security or strategy.

New stock analysis in your inbox.

Independent equity research on under-the-radar companies from lf0 — free, when new work publishes.




No spam. Unsubscribe anytime.

Prefer Substack? Follow lf0 Research on Substack

Leave a Comment

Your email address will not be published. Required fields are marked *